207 related articles for article (PubMed ID: 25064526)
1. Retinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity.
Nallamshetty S; Le PT; Wang H; Issacsohn MJ; Reeder DJ; Rhee EJ; Kiefer FW; Brown JD; Rosen CJ; Plutzky J
Bone; 2014 Oct; 67():281-91. PubMed ID: 25064526
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of retinaldehyde dehydrogenase 1 induces BMP2 and increases bone mass in vivo.
Nallamshetty S; Wang H; Rhee EJ; Kiefer FW; Brown JD; Lotinun S; Le P; Baron R; Rosen CJ; Plutzky J
PLoS One; 2013; 8(8):e71307. PubMed ID: 23951127
[TBL] [Abstract][Full Text] [Related]
3. Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
Yanik SC; Baker AH; Mann KK; Schlezinger JJ
Toxicol Sci; 2011 Aug; 122(2):476-88. PubMed ID: 21622945
[TBL] [Abstract][Full Text] [Related]
4. Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism.
Kiefer FW; Orasanu G; Nallamshetty S; Brown JD; Wang H; Luger P; Qi NR; Burant CF; Duester G; Plutzky J
Endocrinology; 2012 Jul; 153(7):3089-99. PubMed ID: 22555438
[TBL] [Abstract][Full Text] [Related]
5. Concerted action of aldehyde dehydrogenases influences depot-specific fat formation.
Reichert B; Yasmeen R; Jeyakumar SM; Yang F; Thomou T; Alder H; Duester G; Maiseyeu A; Mihai G; Harrison EH; Rajagopalan S; Kirkland JL; Ziouzenkova O
Mol Endocrinol; 2011 May; 25(5):799-809. PubMed ID: 21436255
[TBL] [Abstract][Full Text] [Related]
6. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
[TBL] [Abstract][Full Text] [Related]
7. S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis.
Cao Y; Gomes SA; Rangel EB; Paulino EC; Fonseca TL; Li J; Teixeira MB; Gouveia CH; Bianco AC; Kapiloff MS; Balkan W; Hare JM
J Clin Invest; 2015 Apr; 125(4):1679-91. PubMed ID: 25798618
[TBL] [Abstract][Full Text] [Related]
8. Retinaldehyde represses adipogenesis and diet-induced obesity.
Ziouzenkova O; Orasanu G; Sharlach M; Akiyama TE; Berger JP; Viereck J; Hamilton JA; Tang G; Dolnikowski GG; Vogel S; Duester G; Plutzky J
Nat Med; 2007 Jun; 13(6):695-702. PubMed ID: 17529981
[TBL] [Abstract][Full Text] [Related]
9. Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cells.
Baker AH; Watt J; Huang CK; Gerstenfeld LC; Schlezinger JJ
Chem Res Toxicol; 2015 Jun; 28(6):1156-66. PubMed ID: 25932594
[TBL] [Abstract][Full Text] [Related]
10. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
[TBL] [Abstract][Full Text] [Related]
11. PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss.
Wei W; Wang X; Yang M; Smith LC; Dechow PC; Sonoda J; Evans RM; Wan Y
Cell Metab; 2010 Jun; 11(6):503-16. PubMed ID: 20519122
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinedione treatment and constitutive-PPARgamma activation induces ectopic adipogenesis and promotes age-related thymic involution.
Youm YH; Yang H; Amin R; Smith SR; Leff T; Dixit VD
Aging Cell; 2010 Aug; 9(4):478-89. PubMed ID: 20374200
[TBL] [Abstract][Full Text] [Related]
13. Genetic inhibition of PPARγ S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis.
Ge C; Zhao G; Li B; Li Y; Cawthorn WP; MacDougald OA; Franceschi RT
Bone; 2018 Feb; 107():1-9. PubMed ID: 29107124
[TBL] [Abstract][Full Text] [Related]
14. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.
Lazarenko OP; Rzonca SO; Suva LJ; Lecka-Czernik B
Bone; 2006 Jan; 38(1):74-84. PubMed ID: 16137931
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1A1: friend or foe to female metabolism?
Petrosino JM; Disilvestro D; Ziouzenkova O
Nutrients; 2014 Mar; 6(3):950-73. PubMed ID: 24594504
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
Lin TH; Yang RS; Tang CH; Lin CP; Fu WM
Bone; 2007 Oct; 41(4):562-74. PubMed ID: 17669705
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development.
Gasparetto M; Sekulovic S; Brocker C; Tang P; Zakaryan A; Xiang P; Kuchenbauer F; Wen M; Kasaian K; Witty MF; Rosten P; Chen Y; Imren S; Duester G; Thompson DC; Humphries RK; Vasiliou V; Smith C
Exp Hematol; 2012 Apr; 40(4):318-29.e2. PubMed ID: 22198153
[TBL] [Abstract][Full Text] [Related]
18. De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.
Hamza MS; Pott S; Vega VB; Thomsen JS; Kandhadayar GS; Ng PW; Chiu KP; Pettersson S; Wei CL; Ruan Y; Liu ET
PLoS One; 2009; 4(3):e4907. PubMed ID: 19300518
[TBL] [Abstract][Full Text] [Related]
19. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex.
Ziouzenkova O; Plutzky J
FEBS Lett; 2008 Jan; 582(1):32-8. PubMed ID: 18068127
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Prolyl Hydroxylase Domain Protein in the Rosiglitazone-Induced Suppression of Osteoblast Differentiation.
Kang JH; Kwak HJ; Choi HE; Kim J; Hong S; Kim OH; Oh BC; Cheon HG
PLoS One; 2015; 10(9):e0139093. PubMed ID: 26418009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
